Fortress Biotech Inc (FBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $62.70M
Last updated: Nov 17, 2026 at 11:04 AM ET
Fortress Biotech Inc (FBIO) Stock Forecast
Analysts expect Fortress Biotech (FBIO) to earn $2.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $78.79M. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.00.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a profit to a loss and revenue estimates rise 43.7%.
- Fiscal year ending Dec 31, 2026
- $2.55
- EPS consensus, revenue $78.79M
- Fiscal year ending Dec 31, 2027
- -$1.00
- EPS consensus, revenue $113.25M
- Next report
- Mar 29, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.55 | $2.55 to $2.55 | 1 | $78.79M | $78.79M to $78.79M | 1 |
| Dec 31, 2027 | -$1.00 | -$1.00 to -$1.00 | 1 | $113.25M | $113.25M to $113.25M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.26 | N/A | 3 | $22.91M | $22.01M to $23.59M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.2% from $2.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.55 | $2.40 | $2.40 | $2.40 | $2.40 | +6.2% |
| Fiscal year ending Dec 31, 2027 | -$1.00 | -$0.50 | -$0.50 | $0.51 | $0.51 | N/A |
Frequently Asked Questions About FBIO
What is the FBIO stock forecast?
Consensus analyst estimates put Fortress Biotech's EPS at $2.55 for the fiscal year ending Dec 31, 2026, on revenue of $78.79M.
What EPS do analysts expect from FBIO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.55, with estimates from $2.55 to $2.55 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.00, with estimates from -$1.00 to -$1.00 from 1 analyst.
What revenue do analysts expect from Fortress Biotech next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $78.79M, with estimates from $78.79M to $78.79M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $113.25M, with estimates from $113.25M to $113.25M.
How many analysts cover FBIO?
1 analyst estimates EPS for Fortress Biotech for the fiscal year ending Dec 31, 2026.
FBIO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors